UNSPSC 51182501: Levothyroxine/liothyronine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS851. This VA Drug Class (HS851) classifies this compound as belonging to the group THYROID SUPPLEMENTS.

UNSPSC 51182501 Levothyroxine/liothyronine is a Commodity code covering synthetic thyroid hormone medications that state and local health systems, school districts, correctional facilities, and public health agencies procure for patient care and treatment programs. Levothyroxine—the synthetic form of thyroxine used to treat hypothyroidism—and liothyronine, its synthetic counterpart triiodothyronine, are among the most commonly dispensed medications in public healthcare settings, making this code relevant to state Medicaid agencies, county health departments, municipal hospitals, regional medical centers, and detention systems that maintain on-site pharmacy operations or medication management programs.

The source provides no recent state or local contract opportunities under this code. Without current solicitation activity, issuing-body concentration, geographic patterns, and representative procurements cannot be characterized from available data.